Cargando…
The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview
There are multiple concerns associated with methotrexate (MTX), widely recognized for anti-neoplastic and anti-inflammatory effects in life-threatening disease conditions, i.e., acute lymphoblastic leukemia, non-Hodgkin’s lymphoma, psoriasis, and rheumatoid arthritis, due to long-term side effects a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608860/ https://www.ncbi.nlm.nih.gov/pubmed/36296329 http://dx.doi.org/10.3390/microorganisms10102053 |
_version_ | 1784818871951163392 |
---|---|
author | Marin, Gheorghe-Eduard Neag, Maria-Adriana Burlacu, Codrin-Constantin Buzoianu, Anca-Dana |
author_facet | Marin, Gheorghe-Eduard Neag, Maria-Adriana Burlacu, Codrin-Constantin Buzoianu, Anca-Dana |
author_sort | Marin, Gheorghe-Eduard |
collection | PubMed |
description | There are multiple concerns associated with methotrexate (MTX), widely recognized for anti-neoplastic and anti-inflammatory effects in life-threatening disease conditions, i.e., acute lymphoblastic leukemia, non-Hodgkin’s lymphoma, psoriasis, and rheumatoid arthritis, due to long-term side effects and associated toxicity, which limits its valuable potential. MTX acts as an inhibitor of dihydrofolate reductase, leading to suppression of purine and pyrimidine synthesis in high metabolic and turnover cells, targeting cancer and dysregulated immune cells. Due to low discrimination between neoplastic cells and naturally high turnover cells, MTX is prone to inhibiting the division of all fast-dividing cells, causing toxicity in multiple organs. Nutraceutical compounds are plant-based or food-derived compounds, used for their preventive and therapeutic role, ascertained in multiple organ dysfunctions, including cardiovascular disease, ischemic stroke, cancer, and neurodegenerative diseases. Gut microbiota and microbiota-derived metabolites take part in multiple physiological processes, their dysregulation being involved in disease pathogenesis. Modulation of gut microbiota by using nutraceutical compounds represents a promising therapeutic direction to restore intestinal dysfunction associated with MTX treatment. In this review, we address the main organ dysfunctions induced by MTX treatment, and modulations of them by using nutraceutical compounds. Moreover, we revealed the protective mechanisms of nutraceuticals in MTX-induced intestinal dysfunctions by modulation of gut microbiota. |
format | Online Article Text |
id | pubmed-9608860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96088602022-10-28 The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview Marin, Gheorghe-Eduard Neag, Maria-Adriana Burlacu, Codrin-Constantin Buzoianu, Anca-Dana Microorganisms Review There are multiple concerns associated with methotrexate (MTX), widely recognized for anti-neoplastic and anti-inflammatory effects in life-threatening disease conditions, i.e., acute lymphoblastic leukemia, non-Hodgkin’s lymphoma, psoriasis, and rheumatoid arthritis, due to long-term side effects and associated toxicity, which limits its valuable potential. MTX acts as an inhibitor of dihydrofolate reductase, leading to suppression of purine and pyrimidine synthesis in high metabolic and turnover cells, targeting cancer and dysregulated immune cells. Due to low discrimination between neoplastic cells and naturally high turnover cells, MTX is prone to inhibiting the division of all fast-dividing cells, causing toxicity in multiple organs. Nutraceutical compounds are plant-based or food-derived compounds, used for their preventive and therapeutic role, ascertained in multiple organ dysfunctions, including cardiovascular disease, ischemic stroke, cancer, and neurodegenerative diseases. Gut microbiota and microbiota-derived metabolites take part in multiple physiological processes, their dysregulation being involved in disease pathogenesis. Modulation of gut microbiota by using nutraceutical compounds represents a promising therapeutic direction to restore intestinal dysfunction associated with MTX treatment. In this review, we address the main organ dysfunctions induced by MTX treatment, and modulations of them by using nutraceutical compounds. Moreover, we revealed the protective mechanisms of nutraceuticals in MTX-induced intestinal dysfunctions by modulation of gut microbiota. MDPI 2022-10-18 /pmc/articles/PMC9608860/ /pubmed/36296329 http://dx.doi.org/10.3390/microorganisms10102053 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Marin, Gheorghe-Eduard Neag, Maria-Adriana Burlacu, Codrin-Constantin Buzoianu, Anca-Dana The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview |
title | The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview |
title_full | The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview |
title_fullStr | The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview |
title_full_unstemmed | The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview |
title_short | The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models—An Overview |
title_sort | protective effects of nutraceutical components in methotrexate-induced toxicity models—an overview |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608860/ https://www.ncbi.nlm.nih.gov/pubmed/36296329 http://dx.doi.org/10.3390/microorganisms10102053 |
work_keys_str_mv | AT maringheorgheeduard theprotectiveeffectsofnutraceuticalcomponentsinmethotrexateinducedtoxicitymodelsanoverview AT neagmariaadriana theprotectiveeffectsofnutraceuticalcomponentsinmethotrexateinducedtoxicitymodelsanoverview AT burlacucodrinconstantin theprotectiveeffectsofnutraceuticalcomponentsinmethotrexateinducedtoxicitymodelsanoverview AT buzoianuancadana theprotectiveeffectsofnutraceuticalcomponentsinmethotrexateinducedtoxicitymodelsanoverview AT maringheorgheeduard protectiveeffectsofnutraceuticalcomponentsinmethotrexateinducedtoxicitymodelsanoverview AT neagmariaadriana protectiveeffectsofnutraceuticalcomponentsinmethotrexateinducedtoxicitymodelsanoverview AT burlacucodrinconstantin protectiveeffectsofnutraceuticalcomponentsinmethotrexateinducedtoxicitymodelsanoverview AT buzoianuancadana protectiveeffectsofnutraceuticalcomponentsinmethotrexateinducedtoxicitymodelsanoverview |